INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-0.79 Cr | ₹4.28 Cr | ₹-6.67 Cr | ₹-5.40 Cr | ₹-1.75 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-0.79 Cr |
| Mar2024 | ₹4.28 Cr |
| Mar2023 | ₹-6.67 Cr |
| Mar2022 | ₹-5.40 Cr |
| Mar2021 | ₹-1.75 Cr |
How is Cash Flow from Investing Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.79 Cr | Negative | |
| Mar2024 | ₹4.28 Cr | Positive | |
| Mar2023 | ₹-6.67 Cr | Negative | |
| Mar2022 | ₹-5.40 Cr | Negative | |
| Mar2021 | ₹-1.75 Cr | - | |
Compare Cash Flow from Investing Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹154.8 Cr | 1.2% | -9.5% | -46.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,033.3 Cr | 12.5% | -0.4% | -40% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,343.8 Cr | 1.1% | 5.5% | 11.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,411.8 Cr | 7.8% | 6.6% | 28.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹907.7 Cr | -3.4% | -1.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹512.8 Cr | -0.1% | 7.2% | -3.4% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 1.2% |
-9.5% |
-46.6% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses